Analgesics - Zimbabwe | Statista Market Forecast

In Zimbabwe, the revenue generated in the Analgesics market is estimated to be US$22.60m in 2024.
It is projected that the market will experience an annual growth rate of -0.03% (CAGR 2024-2029).
When compared globally, the United States leads in revenue generation, with US$7.24bn in 2024.
In terms of per person revenues, US$1.33 is generated in 2024.
In Zimbabwe, there has been a growing demand for analgesics in the OTC Pharmaceuticals market due to the increasing prevalence of chronic pain conditions.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Zimbabwe is experiencing significant growth, driven by changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: In Zimbabwe, customers are increasingly seeking pain relief solutions that are effective, affordable, and easily accessible. They prioritize products that provide quick and long-lasting relief from various types of pain, including headaches, muscle aches, and joint pains. Additionally, customers are becoming more conscious of the ingredients used in analgesic products and are opting for natural and herbal alternatives. They also prefer products that are easy to use and have minimal side effects.

Trends in the market: One of the key trends in the Analgesics market in Zimbabwe is the growing demand for over-the-counter (OTC) analgesic products. Customers are increasingly relying on self-medication and are seeking OTC products that can provide immediate relief without the need for a prescription. This trend is driven by the convenience and cost-effectiveness of OTC products, as well as the limited accessibility of healthcare professionals in certain areas. As a result, pharmaceutical companies are focusing on developing and marketing OTC analgesics to cater to this growing demand.Another trend in the market is the rising popularity of topical analgesics. These products, such as creams, gels, and patches, are applied directly to the affected area to provide localized pain relief. Topical analgesics are preferred by customers who want targeted relief for specific areas, such as joint or muscle pain. The ease of application and absence of systemic side effects make these products appealing to customers. As a result, pharmaceutical companies are expanding their product portfolios to include a wide range of topical analgesics.

Local special circumstances: Zimbabwe has a high prevalence of chronic diseases, such as arthritis and migraines, which contribute to the demand for analgesic products. The aging population and changing lifestyles are also factors driving the need for pain relief solutions. Additionally, the limited availability of healthcare services in certain areas makes self-medication with analgesics a common practice. These local special circumstances create a favorable environment for the growth of the Analgesics market in Zimbabwe.

Underlying macroeconomic factors: The growing middle class in Zimbabwe, coupled with increasing disposable incomes, is fueling the demand for analgesic products. As people have more purchasing power, they are able to afford healthcare products and are willing to spend on pain relief solutions. Additionally, the expanding retail sector and the penetration of modern trade channels are making analgesic products more accessible to customers across the country. The stable economic conditions and government initiatives to improve healthcare infrastructure are also contributing to the growth of the Analgesics market in Zimbabwe.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.